Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2003-12-01
2011-10-25
Chen, Shin-Lin (Department: 1632)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S320100, C536S023500, C536S024100
Reexamination Certificate
active
08043855
ABSTRACT:
The invention encompasses the use of gene therapy for the treatment of different kinds of fibrosis in human beings. Specifically, the invention encompasses the use of therapeutic genes specifically directed to target organs to revert and/or prevent the development of the fibrosis process. The invention further encompasses genes encoding for proteins including human MMP-8 active and latent, MMP-1, MMP-2, MMP-9 and MMP-13; human uPA wild type and/or modified (or its truncated version), the truncated receptor for TGF-β type II and Smad-7, which can be directed by adenovirus and/or other recombinant vectors that cannot transduce (i.e., infect) others organs. The gene therapy of the invention further encompasses treating disorders including renal fibrosis, pulmonary fibrosis, hypertrophic and keloid scars (i.e., skin fibrosis), and other kinds of fibrosis.
REFERENCES:
patent: 5166320 (1992-11-01), Wu et al.
patent: 5240846 (1993-08-01), Collins et al.
patent: 5521291 (1996-05-01), Curiel et al.
patent: 5547932 (1996-08-01), Curiel et al.
patent: 5559099 (1996-09-01), Wickham et al.
patent: 5585362 (1996-12-01), Wilson et al.
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5712136 (1998-01-01), Wickham et al.
patent: 5756086 (1998-05-01), McClelland et al.
patent: 5770442 (1998-06-01), Wickham et al.
patent: 5827703 (1998-10-01), Debs et al.
patent: 5846782 (1998-12-01), Wickham et al.
patent: 5856152 (1999-01-01), Wilson et al.
patent: 5871982 (1999-02-01), Wilson et al.
patent: 5872154 (1999-02-01), Wilson et al.
patent: 5885808 (1999-03-01), Spooner et al.
patent: 5895759 (1999-04-01), Strauss et al.
patent: 5910487 (1999-06-01), Yew et al.
patent: 5922576 (1999-07-01), He et al.
patent: 5980886 (1999-11-01), Kay et al.
patent: 6265212 (2001-07-01), Fallaux et al.
patent: 6436393 (2002-08-01), Bilbao et al.
patent: 6686198 (2004-02-01), Melton et al.
patent: WO 96/18419 (1996-06-01), None
patent: WO 97/17090 (1997-05-01), None
patent: WO 98/48024 (1998-10-01), None
Deonarain, M.,1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69.
Verma, et al., Sep. 1997, Nature, vol. 389, pp. 239-242.
Eck et al., 1996, Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, p. 77-101.
Gorecki, 2001, Expert Opin. Emerging Drugs, 6(2): 187-198.
Rudinger, 1976, Peptide Hormones, Edited by Parsons, University Park Press, Baltimore, p. 1-7.
Kaye et al., 1990, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6922-6926.
Davis, C. G., 1990, The New Biologist, vol. 2, No. 5, p. 410-419.
Skolnick et al., 2000, Trends in Biotech, vol. 18, p. 34-39.
Hattori et al., Jan. 1999, Human Gene Therapy, vol. 10, No. 2, pp. 215-222.
Jaffe et al., Apr.-May 1999, Experimental Lung Research, vol. 25, No. 3, pp. 199-215.
Li et al., Aug. 1998, Gene Therapy, vol. 5, p. 1105-1113.
Varga et al., 2007, The Journal of Clinical Investigation, vol. 117, No. 3, p. 557-567.
Fernandez et al., 1998, Surgery, vol. 124, p. 129-136.
Hasty et al., 1990, The Journal of Biological Chemistry, vol. 265, No. 20, pp. 11421-11424.
Baker et al., 1996, Matrix Biology, vol. 15, pp. 383-395.
Brinckerhoff et al., 1987, Journal of Clinical Investigation, vol. 79, p. 542-546.
Devarajan et al., 1992, The Journal of Biological Chemistry, vol. 267, No. 35, p. 25228-25232.
Freije et al., 1994, Journal of Biological Chemistry, vol. 269, No. 24, p. 16766-16773.
Tomasinsig et al., 2005, Current Protein and Peptide Science, vol. 6, p. 23-34.
Smallwood et al., 2002, Virology, vol. 304, p. 135-145.
Chattopadhyay et al., 2004, Virus Research, vol. 99, p. 139-145.
P. P. Anthony, K. G. Hishack, N. C. Nayak, H. E. Poulsen, P. J. Scheuer, L. H. Sobin; “The Morphology of Cirrhosis: Definition, Nomenclature and Classification”,Bulletin of the World Health Organization; 1977; 55:521-540.
J. Armendariz-Borunda and M. Rojkind; “A Simple Quantitative Method for Collagen Typing in Tissue Samples: Its Application to Human Liver with Schistosomiasis”;Collagen Rel. Res.1984, vol. 4, 35-47.
J. Armendariz-Borunda, K. Katayama and J. M. Seyer; “Transcriptional Mechanisms of Type I Collagen Gene Expression are Differentially Regulated by Interleukin-1β, Tumor Necrosis Factor α, and Transforming Growth Factor β in Ito Cells”;J. Biol. Chem.267:14316-14321; 1992.
J. Armendariz-Borunda, H. Katai, C. M. Jones, J. M. Seyer, A. H. Kang, and R. Raghow; “Transforming Growth Factor β Gene Expression is Transiently Enhanced at a Critical Stage during Liver Regeneration Following CCI4Treatment”;Laboratory Investigation; 69:283-294, 1993.
J. Armendariz-Borunda, C. Simkevich, N. Roy, R. Raghow, A. H. Kang and J. M. Seyer , “Activation of Ito Cells Involves Regulation of AP-1 Collagen Gene Expression”;Biochemical Journal304:817-824, 1994.
C. Chen and H. Okayama; “Calcium Phosphate-Mediated Gene Transfer: a Highly Efficient Transfection System for Stably Transforming Cells with Plasmidic DNA”,Biotechniques1988, 6:632-638.
J.T. Douglas and D. T. Curiel, “Adenoviruses as Vectors for Gene Therapy”,Science and Medicine, Mar./Apr. 1997, 44-53.
R. Dumaswala, D. Berkowitz and J. E. Heubi, “Adaptive Response of the Enterohepatic Circulation of Bile Acids to Extrahepatic Cholestiasis”,Hepatology1996, vol. 23, No. 3: 623-629.
Scott L. Friedman, “The Cellular Basis of Hepatic Fibrosis: Mechanisms and Treatment Strategies”,The New England Journal of Medicine1993, vol. 328, No. 25:1828-1835.
F.L. Graham and A. J. Van Der Eb, “A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA”,Virology1973, 52:456-467.
Tong-Chuan He, Shibin Zhou, Luis T. Da Costa, Kian Yu, Kenneth W. Kinzler and Bert Vogelstein, “A Simplified System for Generating Recombinant Adenoviruses”,Proc. Natl. Acad. Sci. USA, vol. 95: 2509-2514, Mar. 1998.
S. Lee, C. Girod, A. Draillon, A. Hadengue, and D. Lebec, “Hemodynamic Characterization of Chronic Bile Duct-Ligated Rats: Effect of Pentobarbital Sodium”,AM Journal Fisiol. 1986; 251:176-180.
Marie-Jeanne T. F. D. Vrancken Peeters, A. Lieber, J. Perkins, and M. A. Kay; “Methods for Multiple Portal Vein Infusion in Mice: Quantitation of Adenovirus-Mediated Hepatic Gene Transfer”;BioTechniquesFeb. 1996; 20:278-285.
D. Martinez-Fong, J. E. Mullersman, A. F. Purchio, J. Armendariz-Borunda, and A. Martinez-Hernandez, “Nonenzymatic Glycosylation of Poly-L-lysine: A New Tool for Targeted Gene Delivery”,Hepatology, vol. 20, No. 6: 1602-1608.
F. Mion, A. Geloen, E. Agosto and Y. Minaire, “Carbon Tetrachloride Induced Cirrhosis in Rats: Influence of the Acute Effects of the Toxin on Glucose Metabolism”,Hepatology1996 vol. 23, No. 2:582-587.
S. Nakano, J. Haratake, and H. Hashimoto, “Alteration in Bile Ducts and Peribiliary Microcirculation in Rats After Common Bile Duct Ligation”;Hepatology, 1995, vol. 21, No. 5, 1380-1386.
J. L. Poo, A. Estanes, J. Pedraza-Chaverri, C. Cruz, C. Perez, A. Huberman and M. Uribe; “Cronologia de Hipertension Portal, Disminucion de Excrecion de sodio y activacion del sistema renina-angiotensina en cirrosis biliar experimental”, Rev.,Invest Clin., 49:15-23, 1997.
A. Rojas-Martinez, P. R. Wyde, C. A. Montgomery, S. H. Chen, S. L. C. Woo, and E. Auilar-Cordova; “Distribution, Persistency, Toxicity and Lack of Replication of an E1A-Deficient Adenoviral Vector after Intracardiac Delivery in the Cotton Rat”;Cancer Gene Ther., vol. 5, 1998, pp. 365-370.
S. Shimohama, M. B. Rosenberg, A. M. Fagan, J. A. Wolff, M. P. Short, X. O. Breakefield, T. Friedmann, and F. H. Gage, “Grafting Genetically Modified Cells into the Rat Brain: Characteristics ofE. Coliβ-Galactosidase as a Reporter Gene”;Molecular Brain Res.5:271-278; 1989.
D. J. Weiss, D. Liggitt and J. G. Clark, “In Situ Histochemical Detection of β-Galactosidase Activity in Lung: Assessment of X-Gal Reagent in DistinguishedlacZGene Expression and Endogenous β-Galactos
Aguilar Cordova Estuardo
Armendariz Borunda Juan
Chen Shin-Lin
Morgan & Lewis & Bockius, LLP
TGT Laboratories, S.A. DE C.V.
LandOfFree
Recombinant adenoviral vectors and their utility in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant adenoviral vectors and their utility in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant adenoviral vectors and their utility in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295233